Blog
RSS FeedPosted by Michael Wonder on 22 Dec 2022
Final report for the post-market review of medicines for smoking cessation and review outcomes
22 December 2022 - The final report for the post-market review of medicines for smoking cessation is now available. The ...
Posted by Michael Wonder on 21 Dec 2022
PBS Expenditure and Prescriptions Report (2021-22)
21 December 2022 - The PBS Expenditure and Prescriptions Report 1 July 2021 to 30 June 2022 is now available. ...
Posted by Michael Wonder on 20 Dec 2022
A National Medicines Policy fit for the future
20 December 2022 - An updated and strengthened National Medicines Policy has been delivered to the Australian Government. ...
Posted by Michael Wonder on 20 Dec 2022
Just released National Medicines Policy sets high ambitions for better health outcomes for all Australians
20 December 2022 - Medicines Australia congratulates the Government on the release of the much anticipated National Medicines Policy, after ...
Posted by Michael Wonder on 20 Dec 2022
Refreshed National Medicines Policy
20 December 2022 - The Australian Government has released an updated and strengthened National Medicines Policy. ...
Posted by Michael Wonder on 19 Dec 2022
New report indicates COVID-19 vaccines saved Australia’s economy
19 December 2022 - Medicines Australia welcomes the latest peer-reviewed research paper indicating the rollout of the COVID-19 vaccinations significantly ...
Posted by Michael Wonder on 18 Dec 2022
EQ-5D-Y-3L value sets, valuation methods and conceptual questions
12 December 2022 - The measurement and valuation of child health-related quality of life is a rapidly evolving field. ...
Posted by Michael Wonder on 16 Dec 2022
Recommendations made by the PBAC – November 2022
16 December 2022 - The outcomes from the November 2022 PBAC meeting are now available. ...
Posted by Michael Wonder on 07 Dec 2022
Updated eligibility for COVID-19 oral treatment
7 December 2022 - COVID-19 treatments can be taken in your own home and can help reduce your symptoms. ...
Posted by Michael Wonder on 06 Dec 2022
Molnupiravir ‘effective Covid-19 anti-viral’: acting CMO Michael Kidd
6 December 2022 - Acting chief medical officer Michael Kidd has contradicted the nation’s top advisers on Covid-19 treatments on ...
Posted by Michael Wonder on 04 Dec 2022
Anti-viral drug should not be first choice in treating COVID-19
3 December 2022 - The most widely prescribed anti-viral drug in Australia, molnupiravir, should no longer be routinely given for ...
Posted by Michael Wonder on 03 Dec 2022
Hopes $55k breast cancer drug Keytruda will get PBS listing
3 December 2022 - Women with triple negative breast cancer have been given new hope that immunotherapy drug Keytruda will ...
Posted by Michael Wonder on 02 Dec 2022
Agenda for the December 2022 PBAC intracycle meeting
2 December 2022 - The agenda for the December 2022 PBAC intracycle meeting is now available. ...
Posted by Michael Wonder on 30 Nov 2022
Schedule of Pharmaceutical Benefits - 1 December 2022
1 December 2022 - The December 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 29 Nov 2022
External consultation on the draft revised post-market review framework (deadline extension)
29 November 2022 - The Department of Health and Aged Care has received a request to extend the consultation period on ...